Part Details | VETERINARY FLUNIXIN MEGLUMINE INJECTION
6509-01-530-4462
Alternate Parts: 050419, 05-0419, 6509NCM050576, 078074229, 07-807-4229, BANAMINE, NDC00061085103, NDC00061-0851-03, FLUNIXAMINE, 6509-01-530-4462, 01-530-4462, 6509015304462, 015304462
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAY 26, 2005 | 01-530-4462 | 67067 ( FLUNIXIN MEGLUMINE INJECTION, VETERINARY ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6509-01-530-4462
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 05-0419 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6509NCM050576 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| 07-807-4229 | 0LE89 | J A WEBSTER INC |
| BANAMINE | 062F6 | SCHERING-PLOUGH ANIMAL HEALTH CORP |
| NDC00061-0851-03 | 062F6 | SCHERING-PLOUGH ANIMAL HEALTH CORP |
| FLUNIXAMINE | 2J167 | WYETH |
Technical Data | NSN 6509-01-530-4462
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY50.000 MILLIGRAMS FLUNIXIN MEGLUMINE |
| PRIMARY CONTAINER TYPE | VIAL, MULTIPLE DOSE |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 MILLILITERS |
| SPECIAL FEATURES | RECOMMENDED FOR THE ALLEVIATION OF INFLAMMATION AND PAIN ASSOCIATED WITH MUSCULOSKELETAL DISORDERS IN THE HORSE; FLUNIXAMINE IS INDICATED FOR THE CONTROL OF PYREXIA ASSOCIATED WITH BOVINE RESPIRATORY DISEASE AND ENDOTOXEMIA; AND ALLEVIATION OF VISCERAL PAIN ASSOCIATED WITH COLIC IN HORSES; FOR IM USE IN HORSES AND FOR IV USE IN BEEF AND NONLACTATING DAIRY CATTLE ONLY; NOT FOR USE IN LACTATING AND DRY DAIRY COWS, AND NOT FOR USE IN VEAL CALVES; MULTIDOSE VIAL, 100ML |
| PROTECTIVE STORAGE FEATURE | |
| SUPPLEMENTARY FEATURES | FOR IM USE IN HORSES AND IV USE IN BEEF |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FLUNIXIN MEGLUMINE INJ VETERINARY USE 50MG/ML 100ML VI |